Prospective Study on Circulating MicroRNAs and Risk of Myocardial Infarction
Anna Zampetaki(University of Verona), Manuel Mayr(King's College London), Stefan Kiechl, Marianna Prokopi(King's College London), Siegfried Weger(University of Verona), Chantal M. Boulanger(Inserm), Ignat Drozdov(King's College London), Agnes Mayr(University of Verona), Phil Chowienczyk(St Thomas' Hospital), Georg Schett(Friedrich-Alexander-Universität Erlangen-Nürnberg), Ajay M. Shah(King's College London), Lindsey Tilling(King's College London), Peter Willeit(Innsbruck Medical University), Jean–Marie Renard(Délégation Paris 5), Johann Willeit(Innsbruck Medical University)
Cited by 463
Related Papers
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
|Circulation Research|2010|1.5k
Cardioprotection and lifespan extension by the natural polyamine spermidine
|Nature Medicine|2016|1.1k
Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality
|JAMA|2005|1.1k
Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide.
|Journal of Clinical Investigation|1990|1.1k